|
Hall 1 |
|||
| 8.15-8:30 | Opening of the event | ||
| 8:30-9:00 | Acknowledgements | ||
| Plenary sessions Moderador: Félix González | |||
| 9:00-9:45 | Epidemiology of Obesity, Diabetes and Cardiovascular DiseaseOscar Diaz Diaz, M.D Cuba | ||
| 9:45-10:30 | Preventive Strategy of Overweight, Obesity and Diabetes, from Theory to Practice.Felix Escano, M.D Dominican Republic | ||
| 10:30-10:45 | Coffee break | ||
|
Hall 1 |
Hall 2 |
||
| 10:45-13:00 | International Symposium ALAD/CUBAModerators: Ileydis Iglesias y Ana ibis Conesa |
Symposium Integrated Management of Diabetic Foot Ulcers with Heberprot-P.Moderators: Eduardo Álvarez y Marisela Trasanco |
|
| 10:45-11:10 | Topicalities and controversies in gestational diabetes..Rafael M. Violante, M.D Mexico | Molecular Biology of Wound Cicatrization, the Contribution of the Recombinant Human Epidermal Growth Factor (EGF hrec)Jorge Berlanga, M.D Cuba | |
| 11:10-11:35 | Women with diabetes at reproductive phase and management of pregnancy planning. . Jacinto Lang, M.D Cuba | Heberprot-P Therapy Changes Paradigms in the Management of Diabetic Foot UlcersJosé Fernández Montequín, M.D Cuba | |
| 11:35-12:00 | Comprehensive Care of the Child and the Adolescent with Diabetes Mellitus in CubaFrancisco Carvajal, M.D Cuba | Drug Surveillance of the Use of Heberprot-P Therapy in the Management of the Diabetic Foot Ulcers in CubaVerena Muzio, M.D Cuba | |
| 12:00-12:25 | Diabetes Mellitus in the Old Age, a New Health Problem?Emilio Bustillo, M.D Cuba. | Integrated Care Program for the Patient with Diabetic Foot Ulcers with the use of Heberprot-P. National and international Results and ProjectionsManuel Raíces, M.D Cuba | |
| 12:25-12:50 | Diabetes/Prediabetes. TherapyJuan Rosas, M.D México. | International Use of Heberprot-P and its Main Results and ProjectionsErnesto López Mola, M.D Cuba | |
| 13:00-14:30 | Lunch | ||
| 14:30-15:00 | Moderator: Francisco Gárciga Bionic Pancreas Technology for Type 1 Diabetes. . John Buse, Ph.D. USA | ||
| 15:00-17:40 | International Symposium ALAD/CUBA Moderators: Oscar Díaz Díaz and Arturo Hernández Yero |
Lectures Moderators: Emilio Buchaca y Marisela Barceló |
|
| 15:00-15:30 | Human Insuline in the Era of Analogues? Manuel Vera, M.D. Cuba. | Some endoluminal procedures for obesity treatment. José Hernández M.D. Cuba |
|
| 15:30-16:00 | Glyfozines: New Therapeutical Class in the Treatment of Type 2 Diabetes Mellitus.José A Mesa, M.D. Mexico | Reducing cardiovascular risk in type 2 diabetes: Issues and opportunities. Jorge Plutzky, M.D. USA |
|
| 16:00-16:30 | Medical Inertia in the Diabetes ManagementFelix Escaño, M.D Dominican Republic | Intra-hospital Management of Diabetes. Ariel Zisman, Ph.D. USA |
|
| 16:30-17:00 | Management of Hyperglycemia and Blood Hypertension in Hospitalized Patients with Cerebrovascular Disease.Manuel Licea, M.D. Cuba | Why oral health is crucial in diabetes management. Wenche Borgnakke, Ph.D. USA |
|
| 17:00-17:30 | Healthy Life Years Lost due to Diabetes in Cuba.Emma Dominguez M.D. Cuba | ADA/EASD type 2 diabetes treatment recommendations. John Buse, Ph.D. USA |
|
|
November 11th |
|||
| 10:45-13:00 | Lectures Moderator: Julieta García |
||
| 10:45-11:10 | Changing epidemiology of type 1 diabetes. Kendra Vehik, M.D. USA |
||
| 11:10-11:35 | Mapping the pathophysiological landscape of the diabetic human pancreas. Dirk Homann, PhD.. USA |
||
| 11:35-12:00 | Diabetes Drug Safety.John Buse, Ph.D. USA | ||
| 12:00-12:25 | Hospital Treatment Protocol of Diabetes Mellitus, Basal-Bolus Therapy. Hospital de Mataró,Enrique Ballestar Mas M.D. Spain | ||
| 12:25-12:50 | Psychological wellbeing and diabetes mellitus-associated vulnerabilities Adriana Agramonte, Bachelor of Science, Cuba |
||
| 13:00-14:30 | Lunch | ||
| 14:30-15:00 | Moderator: José Fernández Montequín The Cuban model for the prevention and treatment of the diabetic foot. Orestes Faget, M.D. Cuba |
||